Loading…

Glycosaminoglycan affinity of the complete fibroblast growth factor family

Many fibroblast growth factor family proteins (FGFs) bind to the heparan sulfate/heparin (HP) subtypes of sulfated glycosaminoglycans (GAGs), and a few have recently been reported to also interact with chondroitin sulfate (CS), another sulfated GAG subtype. To gain additional insight into this inter...

Full description

Saved in:
Bibliographic Details
Published in:Biochimica et biophysica acta 2009, Vol.1790 (1), p.40-48
Main Authors: Asada, Masahiro, Shinomiya, Michiyo, Suzuki, Masashi, Honda, Emi, Sugimoto, Rika, Ikekita, Masahiko, Imamura, Toru
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Many fibroblast growth factor family proteins (FGFs) bind to the heparan sulfate/heparin (HP) subtypes of sulfated glycosaminoglycans (GAGs), and a few have recently been reported to also interact with chondroitin sulfate (CS), another sulfated GAG subtype. To gain additional insight into this interaction, we prepared all currently known FGFs (i.e., FGF1–FGF23) and assessed their affinity for HP, CS-B, CS-D and CS-E. In addition, midkine, hepatocyte growth factor and pleiotrophin were studied as other known HP-binding proteins. We found that members of the FGF19 subfamily (i.e., FGF15, 19, 21 and 23) had little or no affinity for HP; all of the other secretable growth factors tested had strong affinities for HP, as was indicated by the finding that their elution from HP-Sepharose columns required 1.0–1.5 M NaCl. We also found that FGF3, 6, 8 and 22 had strong affinities for CS-E, while FGF5 had a moderate affinity for CS-D. The interactions between FGFs and GAGs thus appear to be more diverse than previously understood. This is noteworthy, as the differential interactions of these growth factors with GAGs may be key determinants of their specific biological activities.
ISSN:0304-4165
0006-3002
1872-8006
DOI:10.1016/j.bbagen.2008.09.001